ABBOTT LABORATORIES — Director's Dealing 2019

Feb 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2019-01-30

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-30	Common shares without par value	M	46017	$44.40	Acquired	100985	Direct
2019-01-30	Common shares without par value	M	84169	$38.40	Acquired	185154	Direct
2019-01-30	Common shares without par value	M	83951	$47	Acquired	269105	Direct
2019-01-30	Common shares without par value	S	177457	$70	Disposed	91648	Direct
2019-01-31	Common shares without par value	M	62600	$47	Acquired	154248	Direct
2019-01-31	Common shares without par value	M	77550	$38.40	Acquired	231798	Direct
2019-01-31	Common shares without par value	F	108090	$71.68	Disposed	111301	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-30	Option (right to buy)	$44.40	M	46017	Disposed	2027-02-16	Common Shares (46017)	Direct
2019-01-30	Option (right to buy)	$38.40	M	84169	Disposed	2026-02-18	Common Shares (84169)	Direct
2019-01-30	Option (right to buy)	$47	M	83951	Disposed	2025-02-19	Common Shares (83951)	Direct
2019-01-31	Option (right to buy)	$47	M	62600	Disposed	2025-02-19	Common Shares (62600)	Direct
2019-01-31	Option (right to buy)	$38.40	M	77550	Disposed	2026-02-18	Common Shares (77550)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	22	Indirect
Common shares without par value	84579	Indirect
Common shares without par value	2595	Indirect
Common shares without par value	12081	Indirect

Footnotes

F1: Excludes 12,407 shares previously directly owned which were transferred to the Jaime Contreras Marvan 2006 Living Trust on September 21, 2018.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2019.

F3: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F4: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F5: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

F6: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.